Navigation Links
DePuy ASR Hip Replacement Lawsuits Moving Along in California, Rottenstein Law Group LLP Reports

(PRWEB) July 19, 2013

DePuy ASR hip lawsuits pending in San Francisco Superior Court are moving apace toward trial dates, reports the Rottenstein Law Group LLP, which maintains an ASR side effects and lawsuits website at A judge has set a July 26 deadline for motions for summary judgment in what will become the first DePuy ASR trial in coordinated proceedings in California, according to court documents.

“This is a typical step for any such case to go to trial,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.

Plaintiff Robert Eugene Ottman’s lawsuit was selected as a bellwether, according to court documents in Ottman v. Johnson & Johnson Services, et al. (CGC-12-517391; California Superior Court.) Ottman alleges that DePuy failed to warn that his DePuy ASR metal-on-metal hip replacement, implanted in 2008, had a defective design that led to his enduring “painful and dangerous complications” that resulted in revision surgery and potentially lifelong problems.

DePuy recalled the ASR in 2010. The product has been under U.S. Food and Drug Administration scrutiny, primarily because of one dangerous alleged side effect called “metal poisoning,” or “metallosis.” According to the FDA*, cobalt and chromium particles could flake off into the implantee’s bloodstream when the device’s metal parts rub together. This could lead to potentially severe health problems.

There are more than a thousand lawsuits consolidated in federal court, according to court documents in In re: DePuy Orthopaedics Inc., ASR Hip Implant Products Liability Litigation (MDL-2197; U.S District Court for the Northern District of Ohio).

The Rottenstein Law Group LLP represents clients in DePuy ASR hip implant lawsuits. The firm encourages those who believe they have suffered from the metal-on-metal ASR’s alleged side effects to visit the firm’s website to download a free brochure to learn more about possible compensation from DePuy ASR lawsuits.


The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New DePuy Knee Sleeve Lawsuit Allegations Information Center for Consumers Announced by Resource4thePeople
2. DePuy Pinnacle Lawyers at Bernstein Liebhard LLP Note Issuance of New Order in Federal DePuy Pinnacle Litigation
3. US Drug Watchdog Now Urges All Recipients Of The Recalled DePuy ASR All Metal Hip Implant In The Few Remaining States Left To Get Signed Up Now-Before Time Runs Out
4. Plaintiff is Replaced in First Bellwether Trial in DePuy ASR Multidistrict Litigation, Notes Parker Waichman LLP
5. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Reports Further Progress in New Jersey State DePuy ASR Recall Litigation
6. US Drug Watchdog Now Urges DePuy Pinnacle Hip Implant Recipients To Call Them About A Vital Blood Test To Determine A Premature Failure-Don't Miss Out On Compensation
7. DePuy ASR Hip Lawsuit News: New Case Substituted for Federal DePuy ASR Litigation’s First Bellwether Trial, Bernstein Liebhard LLP Reports
8. DePuy Hip Replacement Lawsuit News: Lawsuit Chosen for First ASR Trial in Federal Court, Rottenstein Law Group LLP Reports
9. DePuy ASR Hip Recall News: Bernstein Liebhard LLP Comments on Irish Health Services Plan to Launch Major Review of Metal-on-Metal Hip Implants
10. DePuy ASR Lawsuits Progressing, Notes Rottenstein Law Group LLP
11. Arthrex, Depuy Mitek, and Smith & Nephew Lead the $1.5 Billion U.S. Orthopedic Soft Tissue Market, Reports iData Research
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from reveals that behind the tendency to ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: